Onconova Therapeutics (ONTX) Stock: Gaining On License Agreement

Onconova Therapeutics Inc (NASDAQ: ONTX) is having a relatively strong day in the market today, and for good reason. In a press release issued early this morning, the company announced that it has entered into a license agreement. Today, we’ll talk about the agreement, what we’re seeing from the stock, and what we’ll be watching for … Read more

Onconova Therapeutics (ONTX) Stock: Gaining On Clinical Update

Onconova Therapeutics Inc (NASDAQ: ONTX) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company provided an update with regard to their work toward the clinical development of rigosertib. Today, we’ll talk about the update, what we’re seeing from ONTX, and what we’ll be watching for ahead. … Read more

Onconova Therapeutics (ONTX) Stock: Gaining On Positive Preclinical Data

Onconova Therapeutics Inc (NASDAQ: ONTX) Onconova Therapeutics is having an incredibly strong start to the trading session today, and for good reason. The company reported positive pre-clinical data, leading to excitement among investors, which of course pushed the stock upward. As is almost always the case, our partners at Trade Ideas were the first to … Read more

Onconova (ONTX) Moves Higher After Earnings And Trial Update

Onconova Therapeutics Inc (NASDAQ: ONTX) Onconova stock has continued to reward investors, with ONTX up by over 20% since CNA first covered the stock on November 3rd. Average volume (liquidity) has also increased rather substantially, with an average trading volume uptick to over 100K shares per day, up from approximately 55K shares on a historical basis. … Read more

Onconova Therapeutics (ONTX) Stock: Radar Is Forecasting A Strong 2017

Onconova Therapeutics Inc (NASDAQ: ONTX) Onconova Therapeutics, a company founded in 1998, emerged onto the NASDAQ trading market in 2013 after completing an IPO and has maintained a fixation on developing novel and proprietary therapeutics. Currently, ONTX is intently focused upon the treatment of myelodysplastic syndromes, often referred to as MDS. More specific to MDS, … Read more